معرفی
Dr. Martijn Rutten is a Postdoctoral Researcher at the University of Groningen's Faculty of Medical Sciences, specializing in molecular mechanisms of metabolic disorders. His research focuses on glycogen storage diseases (GSD), particularly type Ia, using mouse models to study carbohydrate metabolism, ChREBP signaling, and phenotypic heterogeneity. He also investigates the intersection of sport/longevity and metabolic pathways in cancer biology. Rutten holds a PhD from the University of Groningen (2022) and has collaborated on projects involving CRISPR gene editing, epigenetic therapies, and metabolic disease phenotyping. His work spans biochemistry, cell biology, and translational medicine, with over 12 peer-reviewed publications.
Research Interests: Molecular mechanisms of metabolic disorders, glycogen storage diseases, CRISPR-based gene editing, ChREBP signaling pathways, metabolic modeling in mouse systems, and the impact of physical activity on aging.
Key Contributions: His 2024 study on hepatic ChREBP's role in GSD Ib and 2023 work on C/EBPβ-LIP in cancer metabolism highlight his expertise. Collaborations include studies on atherosclerosis in GSD models and epigenetic treatment strategies for metabolic diseases.
Awards: No specific awards listed, but his research has been widely cited and featured in journals like Molecular Metabolism and Cancer & Metabolism.
Grants & Labs: While specific grants aren't detailed, his involvement in multi-institutional projects (e.g., with Mithieux and Oosterveer groups) indicates collaborative funding. His work is conducted within the Medical Sciences faculty's molecular biology and genetics research clusters.
